1. Home
  2. WRBY

as 12-17-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Ophthalmic Goods

Nasdaq

Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Founded: 2010 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 1.9B IPO Year: 2021
Target Price: $21.00 AVG Volume (30 days): 1.5M
Analyst Decision: Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.27 EPS Growth: N/A
52 Week Low/High: $11.35 - $24.71 Next Earning Date: 11-07-2024
Revenue: $742,527,000 Revenue Growth: 13.47%
Revenue Growth (this year): 16.87% Revenue Growth (next year): 13.10%

WRBY Daily Stock ML Predictions

Stock Insider Trading Activity of Warby Parker Inc. (WRBY)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Gilboa David Abraham WRBY Co-Chief Executive Officer Dec 10 '24 Sell $23.67 358,947 $8,453,614.50 12,306
Blumenthal Neil Harris WRBY Co-Chief Executive Officer Dec 9 '24 Sell $23.65 50,000 $1,182,500.00 12,177
Gilboa David Abraham WRBY Co-Chief Executive Officer Dec 3 '24 Sell $22.61 36,163 $817,645.43 12,306
Blumenthal Neil Harris WRBY Co-Chief Executive Officer Dec 3 '24 Sell $22.61 36,163 $817,645.43 12,177
Miller Steven Clive WRBY Chief Financial Officer Dec 3 '24 Sell $22.61 14,853 $335,826.33 189,146

Share on Social Networks: